News

We have drugs to manage HIV. So why are we spending millions looking for cures?
Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
FDA Approves Powerful Twice-Yearly Treatment to Prevent HIV
Gilead’s Yeztugo will offer an alternative to treatments such as daily pills and every-other-month injections.
National HIV Testing Day Celebrates 30 Years Of Advocacy
National HIV Testing Day has raised awareness and confront stereotypes about HIV. Learn about HIV testing options and ...
SCOTUSblog2d
Justices reject challenge to structure of HHS task force that supported providing coverage for HIV medication
The Supreme Court on Friday rejected a challenge to the structure of a Department of Health and Human Services task force ...
Frontiers2h
Evolution of antiretroviral therapy: Transitioning from three-drug to two-drug HIV regimens
The field of HIV treatment has witnessed a significant transformation since the mid-1990s with the introduction of combination antiretroviral therapy ...
National HIV Testing Day: The importance of early detection and treatment
Without treatment it can lead to deadlier illnesses such as AIDS. HIV also can show no symptoms, meaning testing can be the ...
A University of Utah doctor’s research led to a major HIV drug. He worries federal cuts will stop people from getting it.
The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...
As HIV research gutted at federal level, Northwest Indiana man shares his HIV story
Jeremy Gregson was sitting in his Northwest Indiana home two years ago when he got the call that his blood work from earlier ...